(Q41197240)

28 September 2017

1 reference

title

T-cell recognition of self peptides as tumor rejection antigens (English)

1 reference

28 September 2017

Y Kawakami

1

1 reference

PubMed ID

8902575

28 September 2017

S A Rosenberg

series ordinal

2

1 reference

28 September 2017

1 January 1996

1 reference

28 September 2017

1 reference

28 September 2017

15

1 reference

28 September 2017

3

1 reference

28 September 2017

179-190

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02918248

28 September 2017

0 references

cites work

Tolerance, danger, and the extended family

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02918248

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

21 January 2018

1 reference

12 December 2020

Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy

1 reference

12 December 2020

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

12 December 2020

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma

1 reference

12 December 2020

Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes.

1 reference

12 December 2020

Immunity to Oncogenic Proteins

1 reference

12 December 2020

T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clon

1 reference

12 December 2020

Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.

1 reference

12 December 2020

Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen

1 reference

12 December 2020

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

1 reference

12 December 2020

Peptide binding to MHC class I molecules: implications for antigenic peptide prediction

1 reference

12 December 2020

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

12 December 2020

Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides

1 reference

12 December 2020

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

12 December 2020

Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.

1 reference

12 December 2020

Dominance and crypticity of T cell antigenic determinants

1 reference

12 December 2020

Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic

1 reference

12 December 2020

Identification of tumor-regression antigens in melanoma.

1 reference

12 December 2020

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

1 reference

12 December 2020

Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.

1 reference

12 December 2020

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

12 December 2020

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

12 December 2020

Induction of anti-self-immunity to cure cancer

1 reference

12 December 2020

Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice.

1 reference

12 December 2020

Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues

1 reference

12 December 2020

Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response

1 reference

12 December 2020

Evidence for selection against human lung cancers bearing p53 missense mutations which occur within the HLA A*0201 peptide consensus motif

1 reference

12 December 2020

Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptides

1 reference

12 December 2020

Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70

1 reference

12 December 2020

Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression

1 reference

12 December 2020

Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients

1 reference

12 December 2020

Can antitumor immune responses discriminate between self and nonself?

1 reference

12 December 2020

Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry

1 reference

12 December 2020

Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins

1 reference

12 December 2020

Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans

1 reference

12 December 2020

"Self" to cytotoxic T cells has to be 1,000 or less high affinity nonapeptides per MHC antigen

1 reference

12 December 2020

IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases

1 reference

12 December 2020

CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells

1 reference

12 December 2020

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

12 December 2020

Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A*0201.

1 reference

12 December 2020

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules

1 reference

12 December 2020

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

1 reference

12 December 2020

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

12 December 2020

T-cell recognition of human melanoma antigens

1 reference

12 December 2020

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

1 reference

12 December 2020

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

1 reference

12 December 2020

Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.

1 reference

12 December 2020

Processing of self-proteins and its impact on shaping the T cell repertoire, autoimmunity and immune regulation

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02918248

1 reference

PubMed ID

8902575

Dimensions Publication ID

28 September 2017

0 references

1 reference

PubMed ID

8902575